Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gonadal dysfunction due to cis-platinum.

W H Wallace1, S M Shalet, E C Crowne

  • 1Department of Endocrinology, Christine Hospital and Holt Radium Institute, Manchester, England.

Medical and Pediatric Oncology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-protein meals require 30% additional insulin to prevent delayed postprandial hyperglycaemia.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Late HIV diagnosis and missed opportunities for testing: piloting a standardised, multi-source review process.

International journal of STD & AIDS·2020
Same author

Brain pseudotumour secondary to Behçet's disease.

Annals of the Royal College of Surgeons of England·2019
Same author

Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury.

European journal of endocrinology·2019
Same author

Associations between HbA<sub>1c</sub> and continuous glucose monitoring-derived glycaemic variables.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome.

QJM : monthly journal of the Association of Physicians·2019

Childhood cancer survivors treated with cis-platinum and adriamycin chemotherapy may experience gonadal dysfunction. This study highlights potential ovarian and testicular damage, with higher cis-platinum doses linked to more severe effects.

Area of Science:

  • Pediatric Oncology
  • Reproductive Endocrinology

Background:

  • Osteosarcoma treatment in children often involves chemotherapy.
  • Chemotherapy agents like cis-platinum and adriamycin are used for nonmetastatic osteosarcoma.
  • Long-term effects of these treatments on gonadal function require investigation.

Purpose of the Study:

  • To assess gonadal function in childhood cancer survivors treated with cis-platinum and adriamycin.
  • To identify potential correlations between chemotherapy dosage and gonadal damage.
  • To differentiate the impact of chemotherapy on male and female reproductive health.

Main Methods:

  • Studied gonadal function in 15 patients treated for osteosarcoma during childhood.
  • Assessed pubertal and postpubertal patients using hormone level measurements (gonadotrophins, estradiol, FSH) and physical examinations (testicular volume, sperm count).

Related Experiment Videos

  • Compared cis-platinum dosage between patients with and without gonadal damage.

    • Main Results:

    • Three of seven postpubertal females showed ovarian damage (amenorrhea, elevated gonadotrophins, low estradiol).
    • Three of five pubertal males exhibited oligospermia or reduced testicular volume with elevated gonadotrophins.
    • Higher median cis-platinum doses (490 mg) were significantly associated with gonadal damage compared to normal function (300 mg).

    Conclusions:

    • Chemotherapy regimens including cis-platinum and adriamycin can cause gonadal dysfunction in childhood cancer survivors.
    • Testicular damage in males primarily affected the germinal epithelium, with intact Leydig cell function allowing spontaneous puberty.
    • Ovarian damage in females showed potential for reversibility over time, unlike in males.